成都归合科技

Guihe Technology is a Chengdu-based biotechnology company that leverages artificial intelligence to transform the drug discovery and protein engineering landscape. The company's core competency lies in its proprietary computational platform, which utilizes generative AI and machine learning to design novel proteins and optimize small molecule drug candidates. By integrating high-throughput experimental data with advanced algorithms, Guihe Technology aims to accelerate the identification of high-affinity leads for challenging therapeutic targets. The firm primarily focuses on therapeutic areas such as oncology and immunology, where traditional discovery methods often face significant hurdles. Since its inception, the company has secured backing from leading venture capital firms to expand its R&D capabilities and advance its internal discovery programs.